Common Contracts
10 similar At Market Issuance Sales Agreement contracts by Magnum Hunter Resources Corp, Novavax Inc, Peregrine Pharmaceuticals Inc, others
At Market Issuance Sales AgreementAt Market Issuance Sales Agreement • January 6th, 2010 • Magnum Hunter Resources Corp • Crude petroleum & natural gas • Colorado
Magnum Hunter Resources Corporation, a Delaware corporation formerly known as Petro Resources Corporation (the “Company”), confirms its agreement (this “Agreement”) with Wm Smith & Co., a Colorado corporation (“Wm Smith”), as follows:
Standard Contracts
At Market Issuance Sales AgreementAt Market Issuance Sales Agreement • November 9th, 2009 • Xoma LTD /De/ • Pharmaceutical preparations • New York
XOMA Ltd., a Bermuda company (the “Company”), confirms its agreement (this “Agreement”) with Wm Smith & Co., a Colorado corporation (“Wm Smith”), as follows:
At Market Issuance Sales AgreementAt Market Issuance Sales Agreement • October 15th, 2009 • Generex Biotechnology Corp • Pharmaceutical preparations • New York
Generex Biotechnology Corporation, a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Wm Smith & Co., a Colorado corporation (“Wm Smith”), as follows:
At Market Issuance Sales AgreementAt Market Issuance Sales Agreement • September 16th, 2009 • Magnum Hunter Resources Corp • Crude petroleum & natural gas • Colorado
Magnum Hunter Resources Corporation, a Delaware corporation formerly known as Petro Resources Corporation (the “Company”), confirms its agreement (this “Agreement”) with Wm Smith & Co., a Colorado corporation (“Wm Smith”), which Agreement amends, restates and replaces in its entirely the At Market Issuance Sales Agreement dated as of June 25, 2009, between the Company and Wm Smith, as follows:
At Market Issuance Sales AgreementAt Market Issuance Sales Agreement • September 15th, 2009 • Novavax Inc • Biological products, (no disgnostic substances) • Colorado
Novavax, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Wm Smith & Co., a Colorado corporation (“Wm Smith”), as follows:
At Market Issuance Sales AgreementAt Market Issuance Sales Agreement • July 14th, 2009 • Peregrine Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • Colorado
Peregrine Pharmaceuticals, Inc. a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Wm Smith & Co., a Colorado corporation (“Wm Smith”), as follows:
At Market Issuance Sales AgreementAt Market Issuance Sales Agreement • March 27th, 2009 • Peregrine Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • Colorado
Peregrine Pharmaceuticals, Inc. a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Wm Smith & Co., a Colorado Corporation (“Wm Smith”), as follows:
At Market Issuance Sales AgreementAt Market Issuance Sales Agreement • January 13th, 2009 • Novavax Inc • Biological products, (no disgnostic substances) • Colorado
Novavax Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Wm Smith & Co., a Colorado Corporation (“Wm Smith”), as follows:
ANTIGENICS INC. 9,500,000 Shares Of Common Stock At Market Issuance Sales AgreementAt Market Issuance Sales Agreement • March 14th, 2008 • Antigenics Inc /De/ • Biological products, (no disgnostic substances) • New York
Antigenics Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Wm Smith & Co. (“Wm Smith” and together with the Company, the “Parties”), as follows:
VALENCE TECHNOLOGY, INC. 5,000,000 SHARES At Market Issuance Sales AgreementAt Market Issuance Sales Agreement • February 22nd, 2008 • Valence Technology Inc • Miscellaneous electrical machinery, equipment & supplies • New York
Valence Technology, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Wm Smith & Co. (“Wm Smith”), as follows:
